相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial
Elsemieke de Vries et al.
GASTROENTEROLOGY (2021)
Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients
Mehmet Sayiner et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya F. Gulamhusein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study
Cynthia Levy et al.
JOURNAL OF HEPATOLOGY (2020)
Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial
Amardeep Khanna et al.
HEPATOLOGY (2019)
Fatigue in chronic liver disease: New insights and therapeutic approaches
Mark G. Swain et al.
LIVER INTERNATIONAL (2019)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus
James Meixiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
MRGPRX4 is a bile acid receptor for human cholestatic itch
Huasheng Yu et al.
ELIFE (2019)
Scratching the surface of cholestatic itch treatments
Christopher L. Bowlus
HEPATOLOGY (2018)
Seladelpar’s mechanism of action as a potential treatment for primary biliary cholangitis and non-alcoholic steato-hepatitis
P. Boudes et al.
JOURNAL OF HEPATOLOGY (2018)
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double Blind Placebo Controlled Trial
Marlyn J. Mayo et al.
HEPATOLOGY COMMUNICATIONS (2018)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
Vinod S. Hegade et al.
LANCET (2017)
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review
Hirsh D. Trivedi et al.
AMERICAN JOURNAL OF MEDICINE (2017)
A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis
Marina G. Silveira et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study
V. S. Hegade et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch
Adam Reich et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases
Ewa Wunsch et al.
SCIENTIFIC REPORTS (2016)
A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis
Vinod S. Hegade et al.
FRONTLINE GASTROENTEROLOGY (2016)
Pruritus in Cholestasis: Facts and Fiction
Ulrich Beuers et al.
HEPATOLOGY (2014)
Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid
Marco Carbone et al.
GASTROENTEROLOGY (2013)
The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort
Greta Pells et al.
JOURNAL OF HEPATOLOGY (2013)
Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus
Adam Reich et al.
ACTA DERMATO-VENEREOLOGICA (2012)
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
Harold E. Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The 5-D itch scale: a new measure of pruritus
S. Elman et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Itch in primary billary cirrhosis: A patients' perspective
Eric Rishe et al.
ACTA DERMATO-VENEREOLOGICA (2008)
Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis
U Beuers et al.
HEPATOLOGY (2006)
Dermatological manifestations in primary biliary cirrhosis patients: A case control study
M Koulentaki et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis
A Jacoby et al.
GUT (2005)
Pruritus and fatigue in primary biliary cirrhosis
NV Bergasa et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2000)